IMPLANTABLE ACCESS SYSTEM FOR PROLONGED INTRAPLEURAL IMMUNOTHERAPY

被引：13

作者：

DRIESEN, P

BOUTIN, C

VIALLAT, JR

ASTOUL, PH

VIALETTE, JP

PASQUIER, J

机构：

[1] HOP CONCEPTION,DEPT PULMONOL,F-13385 MARSEILLE 5,FRANCE

[2] INST J PAOLI I CALMETTES,F-13009 MARSEILLE,FRANCE

来源：

EUROPEAN RESPIRATORY JOURNAL | 1994年 / 7卷 / 10期

关键词：

CYTOKINES; INTRAPLEURAL IMMUNOTHERAPY; MESOTHELIOMA; PORT-A-CATH; THORACOSCOPY;

D O I：

10.1183/09031936.94.07101889

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

We describe our experience using an implantable Port-A-Cath access system for intrapleural administration of gamma-interferon (gamma-IFN) in malignant mesothelioma patients. Twenty nine patients, with histologically proven malignant mesotheliomas were included in this study. To avoid complications the device was implanted in a subcutaneous pocket, and the catheter was connected via a tunnel. Also, a suction drain was installed in the pocket after placement. This procedure greatly reduced the high infection rate (64%) encountered with conventional open chest tubes. Patients' tolerance was excellent and maintenance minimal. In our opinion, the Port-A-Cath system is the most suitable device for intracavitary long-term therapy of malignant pleural effusions.

引用

页码：1889 / 1892

页数：4

共 9 条

[1]

BOUTIN C, 1991, CANCER, V67, P2033, DOI 10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO

[2]

2-8

[3]

CRAIG EP, 1984, J CLIN ONCOL, V2, P1277

[4] INTRAPLEURAL ETOPOSIDE FOR MALIGNANT EFFUSION [J].

HOLOYE, PY ;

JEFFRIES, DG ;

DHINGRA, HM ;

HOLMES, FA ;

RABER, M ;

ENGINEER, MS ;

NEWMAN, RA .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (02) :147-150

[5] TREATMENT OF MALIGNANT PLEURAL EFFUSIONS WITH DOXORUBICIN HYDROCHLORIDE-CONTAINING POLY(L-LACTIC ACID) MICROSPHERES [J].

IKE, O ;

SHIMIZU, Y ;

HITOMI, S ;

WADA, R ;

IKADA, Y .

CHEST, 1991, 99 (04) :911-915

[6]

MARKMAN M, 1986, CANCER, V58, P18, DOI 10.1002/1097-0142(19860701)58:1<18::AID-CNCR2820580105>3.0.CO

[7]

2-C

[8]

MONTALDO PG, 1991, J CLIN ONCOL, V47, P55

[9] INTRAPLEURAL CISPLATIN AND CYTARABINE IN THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS - A LUNG-CANCER STUDY-GROUP TRIAL [J].

RUSCH, VW ;

FIGLIN, R ;

GODWIN, D ;

PIANTADOSI, S .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :313-319

← 1 →